Published in Cancer Res on November 15, 2003
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Loss of the transmembrane but not the soluble kit ligand isoform increases testicular germ cell tumor susceptibility in mice. Cancer Res (2008) 1.54
Sequence occurrence and structural uniqueness of a G-quadruplex in the human c-kit promoter. Nucleic Acids Res (2007) 1.24
A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the son. Int J Epidemiol (2010) 1.19
Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers. Mol Cancer (2007) 0.98
Translation initiation factor 4E inhibits differentiation of erythroid progenitors. Mol Cell Biol (2005) 0.95
Cancer stem cells as targets for cancer therapy: selected cancers as examples. Arch Immunol Ther Exp (Warsz) (2008) 0.95
Prognostic value of KIT mutation in gastrointestinal stromal tumors. World J Gastroenterol (2005) 0.94
A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the mother. Int J Epidemiol (2009) 0.93
Molecular genetics of testicular germ cell tumors. Am J Cancer Res (2012) 0.89
New insights into the pathology and molecular biology of human germ cell tumors. World J Urol (2004) 0.88
Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells. Curr Cancer Ther Rev (2006) 0.88
Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells. J Biol Chem (2010) 0.88
Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors. Neoplasia (2005) 0.86
Testicular cancer: biology and biomarkers. Virchows Arch (2014) 0.86
Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis. Endocr Rev (2013) 0.85
Biology of childhood germ cell tumours, focussing on the significance of microRNAs. Andrology (2014) 0.83
Expression of KIT receptor tyrosine kinase in endothelial cells of juvenile brain tumors. Brain Pathol (2009) 0.82
Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages. Neoplasia (2015) 0.80
The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V. Oncogene (2014) 0.78
[Molecular pathology of testicular germ cell tumors: an update]. Pathologe (2008) 0.78
Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis. Asian J Androl (2015) 0.78
Clinical and genetic aspects of testicular germ cell tumours. Hered Cancer Clin Pract (2008) 0.78
Grsf1-induced translation of the SNARE protein Use1 is required for expansion of the erythroid compartment. PLoS One (2014) 0.78
Microinvasive germ cell tumor of the testis. Virchows Arch (2005) 0.77
Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate. Case Rep Oncol (2009) 0.77
Local signalling environments and human male infertility: what we can learn from mouse models. Expert Rev Mol Med (2010) 0.77
Zebrafish models of germ cell tumor. Methods Cell Biol (2011) 0.77
Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure? Nat Rev Urol (2016) 0.75
Synchronous bilateral testis cancer: clinical and oncological management. Contemp Oncol (Pozn) (2017) 0.75
Subfertility and Risk of Testicular Cancer in the EPSAM Case-Control Study. PLoS One (2016) 0.75
Primordial germ cells and gastrointestinal stromal tumors respond distinctly to a cKit overactivating allele. Hum Mol Genet (2012) 0.75
Zebrafish Germ Cell Tumors. Adv Exp Med Biol (2016) 0.75
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature (2005) 18.30
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell (2006) 11.01
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet (2008) 7.14
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell (2004) 3.73
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst (2005) 3.73
Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol (2003) 3.59
Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4. Eur Urol (2007) 3.34
Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol (2008) 3.29
Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer (2005) 3.26
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer. Breast Cancer Res (2007) 3.01
Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology (2002) 2.87
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst (2007) 2.70
Sequence analysis of the protein kinase gene family in human testicular germ-cell tumors of adolescents and adults. Genes Chromosomes Cancer (2006) 2.50
Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet (2010) 2.50
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res (2003) 2.45
Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer. Eur Urol (2013) 2.43
Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev (2006) 2.40
Role of P53 and MDM2 in treatment response of human germ cell tumors. J Clin Oncol (2002) 2.36
The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet (2005) 2.26
Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet (2006) 2.23
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol (2007) 2.21
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol (2007) 2.17
Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review. Eur Urol (2011) 2.11
Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. J Clin Oncol (2009) 2.11
The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability. Mol Cell Biol (2005) 2.11
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Mol Oncol (2007) 2.06
First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases. Clin Cancer Res (2005) 2.04
Intravascular photoacoustic imaging of human coronary atherosclerosis. Opt Lett (2011) 2.00
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer (2008) 1.95
Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer (2005) 1.93
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology (2009) 1.91
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. Eur Urol (2007) 1.89
Paternity following treatment for testicular cancer. J Natl Cancer Inst (2005) 1.87
EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival. J Pathol (2002) 1.86
Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients. Eur Urol (2006) 1.78
Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia. Cancer Cell (2006) 1.76
Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet (2013) 1.74
Atherosclerotic tissue characterization in vivo by optical coherence tomography attenuation imaging. J Biomed Opt (2010) 1.72
Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol (2003) 1.71
The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred. Urol Oncol (2009) 1.70
Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res (2004) 1.67
Maternal and paternal risk factors for cryptorchidism and hypospadias: a case-control study in newborn boys. Environ Health Perspect (2004) 1.66
Minimally invasive autopsy: an alternative to conventional autopsy? Radiology (2009) 1.61
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis. Breast Cancer Res (2005) 1.59
Barriers to the implementation of surveillance for stage I testicular seminoma. Int J Radiat Oncol Biol Phys (2012) 1.58
Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J Clin Oncol (2003) 1.58
A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer. BJU Int (2012) 1.57
Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer. Eur Urol (2010) 1.54
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res (2005) 1.52
Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer. Int J Radiat Oncol Biol Phys (2013) 1.52
FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1. J Cell Biol (2004) 1.51
A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants. Support Care Cancer (2008) 1.50
Tissue-specific splicing factor gene expression signatures. Nucleic Acids Res (2008) 1.49
Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol (2004) 1.47
Study of the factors associated with recurrence in children with sacrococcygeal teratoma. J Pediatr Surg (2006) 1.44
DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. Mol Cancer (2007) 1.44
Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy. Eur Urol (2010) 1.43
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors. J Clin Oncol (2014) 1.42
Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res (2006) 1.41
Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma. Anticancer Res (2009) 1.41
Expression of Ephb2 and Ephb4 in breast carcinoma. Pathol Oncol Res (2004) 1.41
Histopathological and molecular features of late relapses in non-seminomas. BJU Int (2010) 1.40
Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother. BJU Int (2011) 1.39
FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma. Cancer Res (2004) 1.38
CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod Pathol (2004) 1.38
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer. EMBO Mol Med (2013) 1.38
The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study. J Cancer Surviv (2010) 1.37
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study. BJU Int (2008) 1.37
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol (2007) 1.37
Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol (2008) 1.36
Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol (2005) 1.36
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol (2010) 1.36
Beta-globin active chromatin Hub formation in differentiating erythroid cells and in p45 NF-E2 knock-out mice. J Biol Chem (2007) 1.34
Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Int J Cancer (2006) 1.33
Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy. Prostate (2012) 1.33
Self-reported health and use of health care services in long-term cancer survivors. Int J Cancer (2005) 1.29
Ribosomal deficiencies in Diamond-Blackfan anemia impair translation of transcripts essential for differentiation of murine and human erythroblasts. Blood (2011) 1.28
Late relapses of germ cell malignancies: incidence, management, and prognosis. J Clin Oncol (2006) 1.27
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol (2012) 1.26